This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Barbey, J. T. Articles by Zipes, D. P. Search for Related Content PubMed PubMed Citation Articles by Barbey, J. T. Articles by Zipes, D. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Arrhythmia Cardiac Arrest Fainting Hazardous Substances DB CISAPRIDE Social Bookmarking                         What's this?

Spontaneous Adverse Event Reports of Serious Ventricular Arrhythmias, QT Prolongation, Syncope, and Sudden Death in Patients Treated with Cisapride

Departments of Medicine and Pharmacology, Georgetown University Medical Center; Washington, DC

Ralph Lazzara, MD

Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Douglas P. Zipes, MD

Krannert Institute of Cardiology and Division of Cardiology, Indiana University School of Medicine, Indianapolis, IN

Context: Adverse cardiac events, typically long QT syndrome, have been reported in patients treated with the gastrointestinal prokinetic agent cisapride.

Objective: To analyze cases of cisapride-associated long QT syndrome and ascertain the degree of confidence in the diagnosis of long QT syndrome and the presence of risk factors.

Design: Review of all cases reported to the manufacturer, health authorities, or in the medical literature as of October 1999.

Methods: Before review, specific definitions and a classification scheme were agreed upon. Each case was classified by confidence in the long QT syndrome diagnosis and the presence of recognized risk factors (cofactors) or other medical conditions that were listed as contraindications in the June 1998 United States labeling (labeled conditions).

Results: Of 574 cases reviewed, 391 cases of long QT syndrome or isolated QT prolongation were confirmed. Most of these were classified as long QT syndrome with high (145, 37%) or medium (92, 23.5%) confidence in the diagnosis. Recognized cofactors were present in 262 (67%) cases. The proportion of cases with recognized cofactors rose with confidence in the diagnosis (P < 0.001) from 42.2% in the low-confidence group to 68.5% and 82.1% in the medium- and high-confidence groups, respectively. Conversely, the proportion of cases with other labeled conditions decreased with confidence in the diagnosis, from 33.3% for low confidence to 13% and 8.3% for medium and high confidence, respectively. Analysis of cases and prescribing data showed reporting rates decreased in studied months in 1999 compared with the average study period.

Conclusion: In most cases with high or medium confidence in the diagnosis of cisapride associated long QT syndrome, recognized cofactors for long QT syndrome were present. The risk of cisapride-related long QT syndrome may be minimized by avoiding cofactors.

Key Words: long QT syndrome • cisapride • drug interactions

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 7, No. 2, 65-76 (2002)
DOI: 10.1177/107424840200700202


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Darpo Detection and reporting of drug-induced proarrhythmias: room for improvement Europace, September 1, 2007; 9(suppl_4): iv23 - iv36. [Abstract] [Full Text] [PDF]

				B. Darpo, T. Nebout, and P. T. Sager Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline. J. Clin. Pharmacol., May 1, 2006; 46(5): 498 - 507. [Abstract] [Full Text] [PDF]